CIK 0001679628
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
JUPITER NEUROSCIENCES, INC.
Sign in to watch- Ticker
- JUNS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474828381
- Phone
- +1 561-406-6154
- Business address
- 1001 NORTH US HWY 1, SUITE 504, JUPITER, FL, 33477
- Former names
- Jupiter Orphan Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-02 | Weis Holger Director | Grant or award · Stock Option | +100,000 | 100,000 | ||
| 2025-06-02 | Weis Holger Director | Exercise or conversion | +85,800 | 96,581 | ||
| 2025-06-02 | Weis Holger Director | Exercise or conversion · Restricted Stock Units | −85,800 | 0 | ||
| 2025-01-22 | Weis Holger Director | Exercise or conversion | +10,781 | 10,781 | ||
| 2025-01-22 | Weis Holger Director | Exercise or conversion · Convertible Notes | −10,781 | $2.80 | $30K | 10,781 |
Page 1 of 1 · 5 trades